Literature DB >> 28488047

[Differential diagnosis of granulomatous diseases].

B Ehrenstein1, C Brochhausen2,3.   

Abstract

Despite advances in the understanding of the pathophysiology, granulomatous diseases remain a diagnostic challenge for the clinician as well as for the pathologist. However, establishing the correct diagnosis of these diseases is a crucial prerequisite of targeted therapy. It is particularly essential to distinguish between an infectious and a non-infectious cause, since anti-infectious and anti-inflammatory or immunosuppressive approaches are opposing. Failure to establish the correct diagnosis can lead to adverse consequences for the patient. An interdisciplinary approach and a critical assessment of clinical, laboratory-chemical, microbiological, imaging, and anatomical-pathological findings are crucial for the evaluation of granulomatous disorders. This overview summarizes important landmarks and their value in the interplay of arriving at the correct diagnosis.

Entities:  

Keywords:  Biopsy; Fungal infections; Granuloma; Mycobacterial infections; Opportunistic infections

Mesh:

Year:  2017        PMID: 28488047     DOI: 10.1007/s00393-017-0312-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  18 in total

Review 1.  CT patterns of nodular hepatic and splenic sarcoidosis: a review of the literature.

Authors:  G C Scott; J M Berman; J L Higgins
Journal:  J Comput Assist Tomogr       Date:  1997 May-Jun       Impact factor: 1.826

2.  Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.

Authors:  Seong Yeon Park; Sang-Oh Lee; Sang-Ho Choi; Jin-Yong Jeong; Heungsup Sung; Mi-Na Kim; Chang-Min Choi; Sang-Bum Hong; Yeon-Mok Oh; Tae-Sun Shim; Chae-Man Lim; Younsuck Koh; Dong Soon Kim; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

3.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

4.  Rheumatoid nodules: differential diagnosis and immunohistological findings.

Authors:  E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

5.  Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis.

Authors:  Mohammed Azghay; Olivier Bouchaud; Frederic Mechaï; Pascale Nicaise; Olivier Fain; Jérôme Stirnemann
Journal:  Int J Infect Dis       Date:  2016-01-15       Impact factor: 3.623

Review 6.  [PCR-based detection of pathogens in clinical rheumatology].

Authors:  B Ehrenstein; U Reischl
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

7.  [Contrast enhanced sonographic patterns of hepatic candidiasis].

Authors:  C Görg; T Bert; E Klassen; A Neesse; P Barth; A Neubauer
Journal:  Z Gastroenterol       Date:  2010-06-01       Impact factor: 2.000

8.  [Granulomatous lung and systemic diseases].

Authors:  A Prasse; G Kayser; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

Review 9.  Mycotic Infections Acquired outside Areas of Known Endemicity, United States.

Authors:  Kaitlin Benedict; George R Thompson; Stan Deresinski; Tom Chiller
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

Review 10.  Hepatosplenic sarcoidosis: contrast-enhanced ultrasound findings and implications for clinical practice.

Authors:  Claudio Tana; Christoph F Dietrich; Cosima Schiavone
Journal:  Biomed Res Int       Date:  2014-08-18       Impact factor: 3.411

View more
  1 in total

1.  Chronic Granulomatous Inflammation after CyPass® Implantation.

Authors:  Kristina Joana Schoelles; Alexandra Anton; Claudia Auw-Haedrich
Journal:  Ocul Oncol Pathol       Date:  2020-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.